The private-equity firm has agreed to sell its entire stake in India-listed J.B. Chemicals & Pharmaceuticals to Torrent ...

According to the terms announced Sunday, Torrent will purchase a 46.4% interest in JB Pharma at 1,600 rupees ($18.70) per ...

As KKR has delivered stronger returns than the broader Nasdaq Composite over the past year, Wall Street analysts maintain a ...

Shares of KKR & Co. Inc. KKR advanced 4.61% to $127.77 Tuesday, on what proved to be an all-around positive trading session ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $136.8, a high ...

The German cabinet has approved plans to spend 500B on infrastructure over the next 12 years, but KKR's Vincent Policard says ...

(Reuters) -NIQ Global, a consumer insights company backed by investment giant KKR, filed for an initial public offering in ...

The US-based buyout firm is the frontrunner to buy the consumer credit group although other bidders remain in contention, Sky ...

Meta is turning to private credit giants Apollo, KKR, Brookfield, Carlyle and Pimco to secure $29B in debt and equity ...

Torrent said on Sunday that it would acquire a controlling stake in JB Pharma from global investment firm KKR, at an equity ...

Torrent Pharmaceuticals to acquire 46.39% stake in JB Chemicals and Pharmaceuticals, merging to strengthen global presence.

Torrent Pharmaceuticals acquires controlling stake in JB Chemicals and Pharmaceuticals from KKR, followed by merger for ...